Trial Profile
Retrospective study of Rhu-Tnfr-Fc Tepering and Maintenance for Hip Arthritis in Patients with Ankylosing Spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 18 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism